biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Question for Dan Carlson of Tailwinds

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Aug 26, 2023 12:19pm

79 Views

Post# 35606727

RE:RE:RE:Question for Dan Carlson of Tailwinds

I never kept a record of buying, holding and selling that I influenced, TT-Boy.

What I do know is that you and some others accuse me of being so effective that I made victims of you.

That means that you agree that I was VERY effective, so effective that you blame me for your losses.

Look, we know you're angry and not thinking straight.

Just don't make it so obvious.

So what was I? Effective? Not Effective? Make up your mind and stick with it.

I'm not laughing at you. You're falling apart. Get a grip.

jd

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 14, 2024